Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
CA 2182680 A1 · Owner: Van Wagenen, Bradford C. · Inventors: Artman, Linda D.; Moe, Scott T.; Balandrin, Manuel F.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Method for identifying a compound useful for the therapeutic treatment of a neurological disease or disorder such as stroke head trauma, spinal cord injury, epilepsy anxiety, or neurodegenerative diseases such as Alzheimer's Disease Huntington's Disease or, Parkinson's Disease or useful as a muscle relaxant, analgesic or adjuvant to general anesthetics. The compounds is active on a receptoroperated calcium channel, including but not limited to that present as part of an NMDA receptor-ionophore complex a calcium-permeable, AMPA receptor, or a nicotinic cholinergic receptor as a noncompetitive antagonist. The method includes identifying a compound which binds to the receptor-operated calcium …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 26, 1994. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 26, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 26, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.